Ehrlich-Ascites-Tumor-Mouse Expressing Far-Red Turbo FP635
The Ehrlich-Ascites-Tumor-Mouse Expressing Far-Red Turbo FP635 is For Research Use Only
EAT (Ehrlich-Lettre Ascites, mouse breast adenocarcinoma) cells have been stably transfected to express far-red fluorescent TurboFP635. EAT was established as a malignant mouse breast carcinoma. It is widely used in comparative testing of anti-tumor agents. Due to the biophysical properties of TurboFP635 this cell line is especially favorable for in vivo applications such as bio-imaging of tumor progression in real time (e.g. tracing and measuring of tumors in a living animal).
Alternative Name: EAT mouse expressing Far-Red TurboFP635
Specifications
Cell Line: EAT cells expressing far-red fluorescent TurboFP635
Cells/vial: approximately 5 x 105
Subculturing: 1:2 to 1:3
Medium Renewal: 2 to 3 times per week
Growth Medium: RPMI-1640 (2,0 g/L NaHCO3) + 10 % fetal calf serum (FCS), 2 mM L-Alanyl-L-Glutamine, 1 % Non Essential Amino Acids (NEA)
Freeze Medium: Complete growth medium + 10% FCS, 10% DMSO
Shipping: Frozen
Storage Recommendation: Liquid Nitrogen
Biosafety Level: 1
INFORMATION:
Organism: Mus musculus (mouse)
Source: Organ: breast, disease: adenocarcinoma
Tumorgenetic: yes
Growth properties: suspension
Morphology: spherical
Conditions: 37 °C, 5 % CO2
Plasmid: pTurboFP635-C (Evrogen, Moscow, Russia)
Related Products
H460 human lung carcinoma expressing TurboGFP
HeLa human carcinoma expressing TurboGFP
HeLa Human Carcinoma expressing Deep-Red TurboFP602
